Core Viewpoint - The stock price of Yueshen Health has shown significant growth this year, with a year-to-date increase of 41.04%, indicating strong market interest and potential investment opportunities [1][2]. Company Overview - Yueshen Health Group, established on June 8, 1993, and listed on August 23, 2007, is based in Shanghai and primarily operates in high-end ceramic tiles and health-related materials [2]. - The company's main revenue sources include: - Marble tiles: 35.96% - Antique tiles: 31.86% - Health services (wellness/medical/professional education): 11.19% - Warehouse leasing: 8.71% - Other tile products: 13.28% combined [2]. Financial Performance - For the period from January to September 2025, Yueshen Health reported a revenue of 771 million yuan, a year-on-year decrease of 13.23%, while the net profit attributable to shareholders was 3.08 million yuan, reflecting a year-on-year increase of 109.33% [2]. - The company has distributed a total of 89.3 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Market Activity - As of November 12, Yueshen Health's stock price was 4.88 yuan per share, with a trading volume of 31.76 million yuan and a market capitalization of 4.488 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" five times this year, indicating notable trading activity [1].

Core Viewpoint - Shanghai Yueshen Health Group plans to use surplus reserves of 72.85 million yuan and capital reserves of 141 million yuan, totaling 214 million yuan, to offset cumulative losses, resulting in a significant reduction of its reserves and a nearly 400% drop in net profit for 2024 [1][2][4]. Financial Summary - For 2024, the company reported revenue of 1.204 billion yuan, a year-on-year decrease of 5.79%, and a net profit attributable to shareholders of -147 million yuan, a staggering decline of 393.87% [4]. - The company has experienced negative net profits for three consecutive years, with cumulative losses exceeding 500 million yuan, indicating concerns over its core business's ability to generate profits [4]. - The company's operating cash flow also decreased by 33.48% year-on-year, amounting to 82.23 million yuan [4]. Business Transformation - Yueshen Health, originally focused on ceramic tiles, has been transitioning into the health sector since 2015, with its business now encompassing building materials, health services, and investment property leasing [5]. - The company’s building materials segment primarily focuses on high-end ceramic tile brand "Simik," while its health services include various care systems and training programs [5]. Loss Factors - The primary reasons for the company's losses include a decline in revenue from the ceramic tile business due to reduced market demand, increased competition, and rising costs [3]. - The company has also faced challenges related to the long investment cycle of its health projects and asset impairment losses, which have further exacerbated its financial difficulties [4].

上海悦心健康集团股份有限公司 2024 年年度报告全文 上海悦心健康集团股份有限公司 2024 年年度报告 2025 年 2 月 28 日 1 上海悦心健康集团股份有限公司 2024 年年度报告全文 2024 年年度报告 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别 和连带的法律责任。 公司负责人李慈雄、主管会计工作负责人赵一非及会计机构负责人（会 计主管人员）刘晓青声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 有关公司经营风险及应对措施，请参见本报告"第三节 管理层讨论与分 析" 中"十一、公司未来发展的展望"之"（三）可能面对的风险"的相关 具体内容陈述。 公司经本次董事会审议通过的利润分配预案为：以 921,584,303 为基数， 向全体股东每 10 股派发现金红利 0 元（含税），送红股 0 股（含税），不以公 积金转增股本。 2 | 目录 | | --- | | 第一节 重要提示、目录和释义 2 | | | --- | --- | | ...